Wednesday, November 30, 2016

21st Century Cures Act reboot keeps controversial changes for FDA
With the fast-tracked reboot of the 21st Century Cures Act, drug and device manufacturers may be about to win long sought revisions to the way the Food and Drug Administration approves and regulates their products.  READ MORE

No comments: